SCHEMBL29729068

SCHEMBL29729068

CN(C)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1C(=O)c1ccco1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.41
▸ KMT2A Q03164 8/20 0.41
▸ MEN1 O00255 6/20 0.41
▸ POLB P06746 2/20 0.41
▸ THRB P10828 1/20 0.41
▸ APEX1 P27695 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ RAB9A P51151 3/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ CES2 O00748 1/20 0.38
▸ CES1 P23141 1/20 0.38
▸ F2 P00734 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ EGFR P00533 1/20 0.37
▸ SRC P12931 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.36
▸ TSHR P16473 2/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29671224 0.79 HSD11B1 (0.41) ALDH1A1KMT2AMEN1RAB9ANPC1
SCHEMBL29671327 0.71 MAPT (0.43) ALDH1A1KMT2AMEN1RAB9ANPC1
SCHEMBL29671205 0.71 TRPV4 (0.50) ALDH1A1RAB9ANPC1CES2CES1
SCHEMBL29671257 0.71 CA1 (0.50) ALDH1A1KMT2ATDP1RAB9ANPC1
SCHEMBL29671286 0.71 HDAC6 (0.34) F2PKMHDAC3HDAC11HDAC8
SCHEMBL27020189 0.71 HDAC6 (0.34) KMT2AMEN1F2PKMHDAC3
SCHEMBL29671262 0.70 F2 (0.37) F2HDAC3HDAC11HDAC8HDAC6
SCHEMBL29671232 0.70 HDAC6 (0.33) HDAC3HDAC11HDAC8HDAC6
SCHEMBL29671254 0.69 GAA (0.62) ALDH1A1KMT2AMEN1POLBRAB9A
SCHEMBL29671263 0.67 SMN1; SMN2 (0.38) KMT2AMEN1F2PKMHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559454-B2 Benzenesulfonamide derivatives and uses thereof 2692372 ONTARIO, INC. (CA) 2026-02-24 — — US disclosed
US-20220281812-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO INC (CA) 2022-09-08 — — US disclosed
EP-4017843-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 Ontario, Inc. (CA) 2022-06-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559454-B2 Benzenesulfonamide derivatives and uses thereof NR2E1, NR2C2, NR3C1 ALDH1A1 4335/4885KMT2A 4678/4885MEN1 4205/4885
US-20220281812-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF BCR, ARSA, VHL ALDH1A1 2734/4885KMT2A 4188/4885MEN1 3413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback